Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accommodate, ACH, Agentur, Amolyt, analog, ancillary, ANDA, APAM, APLP, Argentina, Artisan, Bach, Baylor, Biden, bilateral, biometric, bolt, Carleton, CDE, Chair, Checkmate, circumvented, Corrupt, Council, counterpart, CPRA, cure, cured, CureVac, cybersecurity, de, deploy, derecognized, devise, dialogue, differentationplasma, disagreement, dosingphase, ejerbog, Emerson, endocrinologist, entertainment, erk, evolution, Exicure, FCPA, fgf, fight, fine, focal, Forsikring, Frazier, Frida, grace, hematology, Henderson, HGIL, hierarchy, Idera, immaterial, immunotherapy, ingredient, inhibitor, Intech, interfering, inventor, ion, irreversible, Janssen, Japanese, JCM, Jersey, Jesper, JHIAIFML, KK, lectured, licensor, lifespan, LIGAND, LLP, longapegsomatropin, longevity, LS, magna, magnitude, main, mark, medium, mek, mental, methoxy, Mill, mineral, mission, misuse, moiety, MSc, necessitate, OBSV, OLE, Pacific, Parliament, Pathology, PCT, PDUFA, pkg, pm, postpone, postponed, PREA, precautionary, prepubertal, prioritization, provisionally, purview, rarity, ratified, rebalance, Relatedly, remote, remotely, rescinded, resume, resumption, revisiting, RVAU, sabotage, send, Silverback, society, software, somapacitan, somatrogon, sophisticated, sophistication, subdomain, surrogate, Synergy, tangible, tasked, Technologiepark, text, toll, topline, Township, truthful, undetected, urgent, verify, Vicore, vigorously, weigh, Wellington, whichever, whilst, Windsor
Removed:
Aggarwal, allocable, analogue, antidrug, AUC, Baccinex, bruising, calcemic, Central, chance, Chen, classification, confirm, constituent, consultancy, counterparty, defer, demonstrating, dependence, disorder, elicited, eliminating, Engleman, entirety, erythema, excise, exiting, extracted, extremely, forming, Frank, Fu, Gaurav, generating, GH, glucagon, headcount, hypercalcemia, improperly, insulin, invalidate, itching, joined, Jonathan, judged, judgment, Kung, lab, Leff, lengthen, lipoatrophy, Master, measure, mild, modify, nodule, Oceania, OPI, OrbiMed, pain, paragraph, partnered, PD, PDMA, picture, post, predicting, promoted, random, reader, reauthorized, remit, resale, reviewer, roll, satisfying, Shan, Silverstein, skin, subgroup, suffering, switch, Tabular, thande, undisputed, unlicensed, VII, younger, Yu
Filing tables
Filing exhibits
Associated ASND transcripts
ASND similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-203040, 333-210810, 333-211512, 333-213412, 333-214843, 333-216883 and 333-228576 on Form S-8 and Registration Nos. 333-209336, 333-211511, 333-216882, 333-223134 and 333-225284 on Form F-3 of our reports dated March 10, 2021, relating to the consolidated financial statements of Ascendis Pharma A/S and the effectiveness of Ascendis Pharma A/S’s internal control over financial reporting appearing in this Annual Report on Form 20-F for the year ended December 31, 2020.
Deloitte Statsautoriseret Revisionspartnerselskab
CVR no. 33963556
/s/ Sumit Sudan | /s/ Lars Hansen | |||
State Authorised Public Accountant | State Authorised Public Accountant |
Copenhagen, Denmark
March 10, 2021